The long term goal of this project is application of antisense oligonucleotides and antisense vectors in treatment of thalassemia. The project is based on a unique application of antisense oligonucleotides in which these compounds are used to restore correct functioning of a defective gene rather than to inhibit the expression of an undesirable gene, as commonly applied. Specifically, antisense oligonucleotides are used to reverse aberrant splicing of human beta-globin pre-mRNA by blocking splice sites activated by the mutations in intron 2 of Beta- globin gene which cause thalassemia. The oligonucleotides not only inhibit aberrant splicing but, by forcing the spliceosome to form on the adjacent correct splice sites, restore correct splicing of beta-globin pre-mRNA and in consequence restore translation of beta-globin polypeptide. In the previous granting period the effective correction of splicing in a number of thalassemic mutants was accomplished both in the cell free splicing extracts and in model cell lines which expressed thalassemic beta-globin transcripts. The main thrust of the work proposed in this application will be to establish the conditions for antisense treatment of thalassemic erythroid cells in vitro and in vivo in animal model.
The specific aims to accomplish these goals are: 1) To optimize the correction of splicing of human thalassemic beta-globin pre-mRNAs by antisense oligonucleotides in K562 cells expressing IVS2-654, IVS2-705 and IVS2-745 mutants. 2) To optimize the effects of antisense oligonucleotides on human beta-globin expression in bone marrow of the IVS2-654 mouse. 3) To treat the IVS2-654 thalassemic mice with antisense oligonucleotides either in a free form or with the aid of delivery agents. 4) To test in K-562 cell lines the correction of splicing of thalassemic beta-globin pre-mRNA by antisense vectors targeted to the aberrant splice sites. 5) To test the antisense snRNA vectors developed in Specific Aim 4 in IVS2-654 mice. To provide high level of expression and to explore the possibility of tissue tropic delivery of antisense sequences the snRNA genes will be incorporated into adeno-associated virus.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL051940-05
Application #
2758544
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1994-12-01
Project End
2002-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Vacek, Marla M; Ma, Hong; Gemignani, Federica et al. (2003) High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA. Blood 101:104-11
Sazani, Peter; Kole, Ryszard (2003) Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J Clin Invest 112:481-6
Suwanmanee, Thipparat; Sierakowska, Halina; Fucharoen, Suthat et al. (2002) Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder. Mol Ther 6:718-26
Gemignani, Federica; Sazani, Peter; Morcos, Paul et al. (2002) Temperature-dependent splicing of beta-globin pre-mRNA. Nucleic Acids Res 30:4592-8
Suwanmanee, Thipparat; Sierakowska, Halina; Lacerra, Giuseppina et al. (2002) Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides. Mol Pharmacol 62:545-53
Mercatante, D R; Bortner, C D; Cidlowski, J A et al. (2001) Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. J Biol Chem 276:16411-7
Gemignani, F; Landi, S; DeMarini, D M et al. (2001) Spontaneous and MNNG-induced reversion of an EGFP construct in HeLa cells: an assay for observing mutations in living cells by fluorescent microscopy. Hum Mutat 18:526-34
Lacerra, G; Sierakowska, H; Carestia, C et al. (2000) Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. Proc Natl Acad Sci U S A 97:9591-6
Gorman, L; Mercatante, D R; Kole, R (2000) Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs. J Biol Chem 275:35914-9
Gorman, L; Suter, D; Emerick, V et al. (1998) Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc Natl Acad Sci U S A 95:4929-34